Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
Asad Mustafa Karim, Jeong Eun Kwon, Tanveer Ali, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115545-115545
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets
Amalia A. Sofianidi, Ecaterina E. Dumbrava, Konstantinos N. Syrigos, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1139-1139
Open Access | Times Cited: 7
Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment
Nuo Cheng, Qianqian Zhou, Zongfang Jia, et al.
Materials Today Bio (2025) Vol. 30, pp. 101441-101441
Open Access
Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
Ming Liu, Li Zheng, Yang Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Advances in Ultrasound-Targeted Microbubble Destruction (UTMD) for Breast Cancer Therapy
Yunfeng Wu, Yu-xi Liu, Han Wu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1425-1442
Open Access
A novel chrysin derivative HYS-072 induces apoptosis and autophagy in Triple-negative breast cancer cells
Yusen Hou, Chenjuan Zeng, Yaosong Yang, et al.
Natural Product Research (2025), pp. 1-7
Open Access
Targeting Pivotal Hallmarks of Cancer for Enhanced Therapeutic Strategies in Triple-Negative Breast Cancer Treatment—In Vitro, In Vivo and Clinical Trials Literature Review
Anna Szulc, Marta Woźniak
Cancers (2024) Vol. 16, Iss. 8, pp. 1483-1483
Open Access | Times Cited: 3
The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma
Mateusz Olbromski, Monika Mrozowska, Aleksandra Piotrowska, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 3
Pioglitazone enhances cisplatin’s impact on triple-negative breast cancer: Role of PPARγ in cell apoptosis
Qamraa H. Alqahtani, Layla A. Al‐Kharashi, Hanaa N. Alajami, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 5, pp. 102059-102059
Open Access | Times Cited: 2
Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review
Adhithya Aravindan, Ashutosh Gupta, Sudheer Moorkoth, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106007-106007
Open Access | Times Cited: 2
Immunotherapy: Constructive Approach for Breast Cancer Treatment
Umer Anayyat, Faiza Ahad, Tobias Achu Muluh, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 925-951
Open Access | Times Cited: 7
Green synthesis of chitosan/silver nanocomposite using kaempferol for triple negative breast cancer therapy and antibacterial activity
Devaraj Bharathi, Ranjithkumar Rajamani, Jaya Ganesh Thiruvengadam Nandagopal, et al.
Environmental Research (2023) Vol. 238, pp. 117109-117109
Closed Access | Times Cited: 6
CLEC3B inhibits proliferation and radioresistance and induces apoptosis in BT549 breast cancer cells
Huawan Chen, Kui Liao, Longhao Li, et al.
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 2, pp. 100895-100895
Open Access | Times Cited: 1
Synergistic anticancer activity of Sulphoraphane and Teriflunomide co loaded lignin nanoparticles against triple negative breast cancer: Targeted nanoparticle delivery and drug repurposing
Debopriya Dutta, Lubna Siddiqui, Sadia Shah, et al.
Medical Hypotheses (2024) Vol. 189, pp. 111404-111404
Closed Access | Times Cited: 1
New evidence for a role of DANCR in cancers: a comprehensive review
Rong Yuan, Zhaojun Xu, Shengkang Zhang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Mechanism of action of resveratrol affecting the biological function of breast cancer through the glycolytic pathway
Yu Gao, Yaoyao Wang, Baodi Wang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Research trends on nanomaterials in triple negative breast cancer (TNBC): a bibliometric analysis from 2010 to 2024
Hongyi Liang, Guoliang Yin, Dandan Feng, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 1
Uncovering metabolic signatures in cancer-derived exosomes: LC-MS/MS and NMR profiling
Nandini Bajaj, Deepika Sharma
Nanoscale (2024)
Closed Access | Times Cited: 1
Computational pathology in the identification of HER2-low breast cancer: Opportunities and challenges
Marie Brevet, Zaibo Li, Anil V. Parwani
Journal of Pathology Informatics (2023) Vol. 15, pp. 100343-100343
Open Access | Times Cited: 3
Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer
H Wang, Ying Chen, Bang Cao, et al.
Medical Science Monitor (2024) Vol. 30
Open Access
YAP1-induced RBM24 promotes the tumorigenesis of triple-negative breast cancer through the β-catenin pathway
Xiaohua Chen, Xiao Lin, Xiaodong Xia, et al.
Journal of Investigative Medicine (2024) Vol. 72, Iss. 5, pp. 403-413
Closed Access
Advancements in Understanding the Hide-and-Seek Strategy of Hibernating Breast Cancer Cells and Their Implications in Oncology from a Broader Perspective: A Comprehensive Overview
Aiman Al-Ruwishan, Bushra Amer, Ahmed F. Salem, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8340-8367
Open Access
Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment
Lingpeng Tang, Dandan Wang, Ting Hu, et al.
Cancer Drug Resistance (2024)
Open Access
Mechanisms of Yiai Fuzheng formula in the treatment of triple-negative breast cancer based on UPLC-Q-Orbitrap-HRMS, network pharmacology, and experimental validation
Ruijie Li, Haoliang Ke, Pan Liu, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36579-e36579
Open Access
Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics
Chiara Guarini, Anna Santoro, Assunta Melaccio, et al.
Expert Opinion on Drug Safety (2024), pp. 1-8
Closed Access
ABO Blood Type and Pretreatment Systemic Inflammatory Response Index Associated with Lymph Node Metastasis in Patients with Breast Cancer
Nating Xiong, Wendao Han, Zhikang Yu
International Journal of General Medicine (2024) Vol. Volume 17, pp. 4823-4833
Open Access
Page 1 - Next Page

Scroll to top